Hana Biosciences Inc. (HNAB.OB) Reports Q4 and FY Results, Notes 2010 Objectives
Hana Biosciences Inc. today posted its fourth quarter and year-end financial results for the period ended Dec. 31, 2009, highlighting recent clinical and corporate updates, as well as 2010 objectives. The company reported a net loss of $5.0 million, or $0.07 per share, for the fourth quarter of 2009 compared with a net loss of $6.1 million, or $0.19 per share, for the fourth quarter of 2008. For the full year ended Dec. 31, 2009, Hana reported a net loss of $24.1 million, or $0.57 per share, compared with a net loss of $22.2 million, or $0.69 per share, for…